What are the next steps as a C.D.C. panel considers Moderna and J. & J. boosters? by BY TODD GREGORY


By BY TODD GREGORY

After the panel makes it recommendations, the agency’s director will issue guidance that will influence the actions of states, hospitals, pharmacies and other entities that distribute the vaccines.

Published: October 21, 2021 at 11:02AM

from NYT Health https://ift.tt/3nj3D4I
via IFTTT

A C.D.C. panel will debate boosters and the ‘mix-and-match’ strategy. by BY APOORVA MANDAVILLI


By BY APOORVA MANDAVILLI

After the F.D.A. issued its authorization of additional doses of vaccines as boosters, it passed the baton to experts advising the Centers for Disease Control and Prevention.

Published: October 21, 2021 at 05:01AM

from NYT Health https://ift.tt/3nbFzks
via IFTTT

Gates Foundation Pledges $120 Million to Help Get Covid Pills Quickly to Poor Countries by BY STEPHANIE NOLEN


By BY STEPHANIE NOLEN

Regulatory hurdles and supply chain issues could slow efforts to produce generic versions of Merck’s antiviral molnupiravir for developing nations, despite licensing agreements.

Published: October 20, 2021 at 09:56AM

from NYT Health https://ift.tt/3AZ0ZG8
via IFTTT